Lighthouse Pharmaceuticals
PrivateLast Round
Series A
Apr 23, 2026
Est. Valuation
$72M
Total Funding Raised
$61.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lighthouse Pharmaceuticals operates in Healthcare & Life Sciences and is based in Novato, California. Its latest recorded funding round was a Series A round in April 2026.
Lighthouse Pharmaceuticals is a biopharmaceutical company that develops small-molecule therapies for neurodegenerative and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lighthouse Pharmaceuticals Comparables
Compare Lighthouse Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Keystone Bio | 83% | |
| Denteric | 77% | |
| MindImmune Therapeutics, Inc. | 69% |
For institutional investors. Book with your work email.
Lighthouse Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 23, 2026 | ||||
| Grant | Aug 22, 2025 |
For institutional investors. Book with your work email.
Lighthouse Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Portfolia | Series A |
| National Institute on Aging | Grant |
| Marin Sonoma Impact Ventures | Series A |
| Double Point Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 823% MoM, reaching 406.
- Apr 23, 2026
$12M round led by Double Point Ventures
For institutional investors. Book with your work email.
Lighthouse Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lighthouse Pharmaceuticals's valuation, stock price, and market status.
Is Lighthouse Pharmaceuticals a public or private company?
Lighthouse Pharmaceuticals is a private company.
What is the current stock price of Lighthouse Pharmaceuticals?
Lighthouse Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Lighthouse Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lighthouse Pharmaceuticals worth (valuation)?
Lighthouse Pharmaceuticals's valuation is estimated at $72.0M based on funding round data.
Can I buy Lighthouse Pharmaceuticals stock?
Lighthouse Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lighthouse Pharmaceuticals's last funding round?
Lighthouse Pharmaceuticals's most recent funding round was Series A on April 23, 2026.
Who are the main investors in Lighthouse Pharmaceuticals?
Key investors in Lighthouse Pharmaceuticals include Double Point Ventures.
Will Lighthouse Pharmaceuticals IPO soon?
No public IPO plans have been announced for Lighthouse Pharmaceuticals.
How can I track Lighthouse Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Lighthouse Pharmaceuticals's shares on secondary markets.